Human Trifunctional Protein Alpha Links Cardiolipin Remodeling to Beta-Oxidation

• William A. Taylor,

  Affiliation Department of Pharmacology and Therapeutics, Center for Research and Treatment of Atherosclerosis, Manitoba Institute of Child Health, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯
• Edgard M. Mejia,

  Affiliation Department of Pharmacology and Therapeutics, Center for Research and Treatment of Atherosclerosis, Manitoba Institute of Child Health, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯
• Ryan W. Mitchell,

  Affiliation Department of Pharmacology and Therapeutics, Center for Research and Treatment of Atherosclerosis, Manitoba Institute of Child Health, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯
• Patrick C. Choy,

  Affiliation Biochemistry and Medical Genetics, Center for Research and Treatment of Atherosclerosis, Manitoba Institute of Child Health, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯
• Genevieve C. Sparagna,

  Affiliation Department of Integrative Physiology, University of Colorado at Boulder, Boulder, Colorado, United States of America

  ⨯
• Grant M. Hatch

  * E-mail: hatchgm@ms.umanitoba.ca

  Affiliations Department of Pharmacology and Therapeutics, Center for Research and Treatment of Atherosclerosis, Manitoba Institute of Child Health, University of Manitoba, Winnipeg, Manitoba, Canada, Biochemistry and Medical Genetics, Center for Research and Treatment of Atherosclerosis, Manitoba Institute of Child Health, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯